C反应蛋白在老年脑梗死中检测的临床价值探讨

发布时间：2018-10-14 13:16

【摘要】：目的针对老年脑梗死患者,讨论实施C反应蛋白的检测价值,为日后的临床检测提供参考与指导。方法选择我院于2014年8月至2016年7月收治的老年脑梗死患者120例为研究对象,设定为观察组;选择同期在我院体检的健康人员为对照组。两组研究对象均实施C反应蛋白检测,对比最终检测结果。结果经过统计,观察组C反应蛋白水平为(11.48±3.25)mg/L,对照组C反应蛋白水平为(6.24±1.70)mg/L,比较差异显著,临床有统计学意义,P0.05,观察组高于对照组。结论老年脑梗死患者是临床上的常见患者,为了更好的治疗,通过对患者实施C反应蛋白检测,可进一步了解患者的病情发展趋势以及自身情况,避免在临床治疗过程中出现偏差。除此之外,可通过阶段性的检查患者指标,为下一个阶段的治疗提供指导,帮助患者取得最佳治疗成果。建议在日后的老年脑梗死患者检测中,将C反应蛋白推广应用。
[Abstract]:Objective to discuss the value of C-reactive protein (CRP) detection in elderly patients with cerebral infarction. Methods 120 elderly patients with cerebral infarction admitted in our hospital from August 2014 to July 2016 were selected as the observation group and the healthy persons in our hospital as the control group. C-reactive protein detection was performed in both groups and the final results were compared. Results the level of C-reactive protein in the observation group was (11.48 卤3.25) mg/L, the level of C-reactive protein in the control group was (6.24 卤1.70) mg/L, the clinical significance was significant (P 0.05), the level of C-reactive protein in the observation group was higher than that in the control group. Conclusion elderly patients with cerebral infarction are common in clinical practice. In order to better treat patients, C-reactive protein detection can further understand the development trend of patients and their own situation. Avoid deviations in the course of clinical treatment. In addition, we can provide guidance for the next stage of treatment through periodic examination of patient indicators to help patients achieve the best results of treatment. It is suggested that C-reactive protein should be extended to the elderly patients with cerebral infarction in the future.
【作者单位】：江苏省常州市新北区春江人民医院;
【分类号】：R743.33

【相似文献】